YOUR BUSINESS AUTHORITY
Springfield, MO
Britain’s AstraZeneca is slated to purchase U.S. drugmaker Alexion Pharmaceuticals.
The deal is valued at $39 billion in cash and stock.
AstraZeneca would bolster its positions in immunology and rare diseases through the deal.
Read more from Reuters.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Ozarks Farm Stop remains open after car crashes into building
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.